Progyny (PGNY) Gains from Investment Securities (2018 - 2019)
Progyny's (PGNY) quarterly Gains from Investment Securities came in at $5.8 million in Q4 2019, up 316.27% year-over-year from $1.4 million in Q4 2018, and down 48.72% quarter-over-quarter from $11.2 million in Q3 2019.
Powered by 
Analysis
Progyny (PGNY) Gains from Investment Securities (2018 - 2019) Analysis & Trends
Progyny (PGNY) has reported Gains from Investment Securities for 2 consecutive years, with $5.8 million the latest figure, recorded in Q4 2019.
- On a quarterly basis, Gains from Investment Securities rose 316.27% year-over-year to $5.8 million in Q4 2019; TTM through Dec 2019 was $18.2 million, a 517.39% increase from a year earlier, with the FY2019 full-year figure at $18.2 million, up 517.39% from the prior year.
- Gains from Investment Securities was $5.8 million for Q4 2019 at Progyny, down from $11.2 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $11.2 million in Q3 2019 and troughed at $184000.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 5.76 Mn |
| Sep 30, 2019 | 11.23 Mn |
| Jun 30, 2019 | 642,000.00 |
| Mar 31, 2019 | 551,000.00 |
| Dec 31, 2018 | 1.38 Mn |
| Sep 30, 2018 | 918,000.00 |
| Jun 30, 2018 | 459,000.00 |
| Mar 31, 2018 | 184,000.00 |